JCHOR

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

EndNote Style
Index
Original Article
Association of histopathologic parameters with angiogenesis and Endoglin in laryngeal squamous cell carcinoma
Aims: Laryngeal squamous cell carcinoma (LSCC) is one of the most prevalent head and neck cancers, characterized by declining survival rates. Understanding prognostic factors is essential for improving patient outcomes, particularly in the context of angiogenesis. This study was designed to comprehensively evaluate the expression of endoglin (CD105) as a marker of angiogenesis in LSCC and to determine its potential association with MVD and other histopathological parameters.
Methods: Forty-two previously untreated patients who underwent laryngectomy and neck dissection were retrospectively included in the current analysis. Regions of highest vascularization (“hot spots”) were delineated, and MVD was assessed using CD105 immunostaining.
Results: Findings from this study reinforce the hypothesis that MVD might not constitute a reliable prognostic biomarker in LSCC, highlighting the complex and multifactorial nature of tumor angiogenesis.
Conclusion: MVD has been reported as an independent prognostic indicator in various malignancies; however, evidence regarding CD105 expression in LSCC remains extremely limited. Previous studies have yielded conflicting results concerning the prognostic significance of MVD in head and neck SCCs, underscoring the complexity of tumor biology. This study adds to the existing discourse, attributing discrepancies to the absence of tumor-specific markers, intratumoral heterogeneity, and methodological variations.


1. Meng XY, Liu J, Lv F, Liu MQ, Wan JM. Study on the correlation between extracellular matrix protein-1 and the growth, metastasis and angiogenesis of laryngeal carcinoma. Asian Pac J Cancer Prev. 2015; 16(6):2313-2316. doi:10.7314/APJCP.2015.16.6.2313
2. Lionello M, Staffieri A, Marioni G. Potential prognostic and therapeutic role for angiogenesis markers in laryngeal carcinoma. Acta Otolaryngol. 2012;132(6):574-582. doi:10.3109/00016489.2011.652308
3. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene. 2003;22(42):6557-6563. doi:10. 1038/sj.onc.1206813
4. Zvrko E, Mikic A, Vuckovic L. CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2009;266(12):1971-1976. doi:10.1007/s 00405-009-0962-3
5. Szafarowski T, Sierdzinski J, Szczepanski MJ, Whiteside TL, Ludwig N, Krzeski A. Microvessel density in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2018;275(7):1845-1851. doi:10. 1007/s00405-018-4996-2
6. Lazaris ACh, Lendari I, Kavantzas N, Kandiloros D, Adamopoulos G, Davaris P. Correlation of tumor markers p53, bcl-2 and cathepsin-D with clinicopathologic features and disease-free survival in laryngeal squamous cell carcinoma. Pathol Int. 2000;50(9):717-724. doi:10.1046/j. 1440-1827.2000.01110.x
7. Kupisz K, Chibowski D, Klatka J, Klonowski S, Stepulak A. Tumor angiogenesis in patients with laryngeal cancer. Eur Arch Otorhinolaryngol. 1999;256(6):303-305. doi:10.1007/s004050050251
8. Beatrice F, Cammarota R, Giordano C, et al. Angiogenesis: prognostic significance in laryngeal cancer. Anticancer Res. 1998;18(6B):4737-4740.
9. Burian M, Quint C, Neuchrist C. Angiogenic factors in laryngeal carcinomas: do they have prognostic relevance?Acta Otolaryngol. 1999; 119(2):289-292. doi:10.1080/00016489950181846
10. Hagedorn HG, Nerlich AG. Microvessel density and endothelial basement membrane composition in laryngeal squamous cell carcinomas. Acta Otolaryngol. 2000;120(7):891-898. doi:10.1080/ 000164800750061796
11. Sarbia M, Bittinger F, Porschen R, Dutkowski P, Willers R, Gabbert HE. Tumor vascularization and prognosis in squamous cell carcinomas of the esophagus. Anticancer Res. 1996;16(4A):2117-2121.
12. MacLennan GT, Bostwick DG. Microvessel density in renal cell carcinoma: lack of prognostic significance. Urology. 1995;46(1):27-30. doi:10.1016/S0090-4295(99)80153-8
13. Dray TG, Hardin NJ, Sofferman RA. Angiogenesis as a prognostic marker in early head and neck cancer. Ann Otol Rhinol Laryngol. 1995; 104(9):724-729. doi:10.1177/000348949510400911
14. Murray JD, Carlson GW, McLaughlin K, et al. Tumor angiogenesis as a prognostic factor in laryngeal cancer.Am J Surg. 1997;174(5):523-526. doi:10.1016/s0002-9610(97)00168-2
15. Marioni G, D’Alessandro E, Giacomelli L, Staffieri A. CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma. J Oral Pathol Med. 2010;39(5):361-367. doi:10.1111/j.1600-0714.2010.00888.x
16. Shpitzer T, Chaimoff M, Gal R, Stern Y, Feinmesser R, Segal K. Tumor angiogenesis as a prognostic factor in early oral tongue cancer Arch Otolaryngol Head Neck Surg. 1996;122;(8):865-868.doi:10.1001/archotol.1996.01890200055012
17. Schimming R, Marmé D. Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity.Head Neck. 2002;24(2):151-156. doi:10. 1002/hed.10040
Volume 3, Issue 4, 2025
Page : 77-81
_Footer